Testing effectiveness (Phase 2)Study completedNCT01968668
What this trial is testing
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Who this might be right for
Diabetic Nephropathies
Bayer 96